The latest threat to the Affordable Care Act could strike down a popular provision that gives 180 million Americans access to free preventive care for conditions including HIV and cancer.
Cancer
Posted inCost of Care
Race to the Bottom: Hard Bargain
America pays less, on average, than any other major country for our generic drugs. But selling essential medicines at such low prices comes with hidden costs — from quality problems to frequent shortages.
Posted inHealth Technology
Hope, Hype or Harm? What We Know About New Cancer-Screening Tools
A doctor walks us through the risks and benefits of new cancer-detecting body scans and blood tests.
Posted inPublic Health
More Hospitals Move to Confront Medical Errors Head On
A growing number of hospitals are adopting programs to discuss and fix medical errors.
Posted inHealth Technology
How a Cancer-Screening Blood Test Could Backfire
A new JAMA Internal Medicine article reviews the evidence for a widely hyped cancer-screening blood test — and finds it lacking.
Posted inCost of Care
What to Expect When Medicare and Pharma Finally Negotiate Drug Prices
We explain how Medicare’s historic price negotiations with drugmakers will work, and the impact they could have.
Posted inInsurance
The Latest Threat to the Affordable Care Act
ACA expert Nicholas Bagley breaks down the court ruling striking down the popular requirement for insurers to offer free preventive care services.
Posted inInsurance
The Push to End Cancer Screening Purgatory
Initial screenings for breast, lung and cervical cancer are free, but expensive secondary tests can leave patients in screening purgatory.
Posted inCost of Care
MRIs, Mammograms and the Risk of Breast Cancer Screening Cascades of Care
Stacie Dusetzina shares new research on how much extra care comes after different kinds of breast cancer screenings.
Posted inCost of Care
High-Price Drugs Out of Reach for Many on Medicare
Bianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.